EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-3.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-77.25%
2024-84.86%
202330.77%
2022-75.04%
2021-28.69%
202020.07%
2019-6.81%
2018-187.64%
201714.21%
2016-439.48%